Skip to main content
. 2015 Jul 15;16(10):1430–1433. doi: 10.1080/15384047.2015.1071734

Figure 3.

Figure 3.

A simplified depiction of the MAPK pathway. Binding to the PDGF or EGF receptor results in activation of the RAS/RAF pathway and subsequent cell proliferation and differentiation. Blockade of the BRAF kinase with vemurafenib halts this process seen in the progression of many cancers.